Glecaprevir/pibrentasvir Clinical Trials

3 actively recruiting trials across 3 locations

No change since May 2026

Also known as: GLE/PIB, Mavyret

Pipeline

Phase 1/2: 1Phase 2/3: 1

Top Sponsors

White River Junction Veterans Affairs Medical Center1
Washington University School of Medicine1
National Institute of Allergy and Infectious Diseases (NIAID)1

Indications

Liver Disease3
Hepatitis C2
Pregnancy Complications1
PTSD1

Los Angeles, California1 trial

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

USC LA

Phase 1/2

St Louis, Missouri1 trial

Feasibility and Acceptability of HCV Treatment in Pregnancy

Barnes Jewish Hospital

White River Junction, Vermont1 trial

Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder

White River Junction VAMC

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.